Insulin Pumps Market (2026-2031) Size, Share, Analysis By Product (Insulin Pumps, Infusion Sets, Infusion Set Insertion Devices), Region (North America, Europe, Asia Pacific) and Segment Forecast

The Insulin Pumps Market is expected to witness a growth rate of 12% by 2031. Increasing prevalence of diabetes, rising demand for portable insulin delivery devices, technological advancements in insulin pumps, advantages offered by insulin pumps such as better outcomes, better patient health, lower HbA1c, rise in base population in emerging markets, improving diabetes diagnosis rate, and increasing treatment rate with insulin are some of the key factors driving the global insulin pumps market.

An insulin pump is a wearable medical device that delivers insulin underneath the skin. Insulin pumps are mostly small, computerized devices that are roughly the size of a juice box or a deck of cards. They serve as an alternative to frequent insulin injections

Untapped Commercial Opportunities Among Both Type I and Type II Diabetic Patients

Diabetes is a silent epidemic that claims millions of lives each year. It is touted as a pandemic of unprecedented magnitude that is spiraling out of control. According to the International Diabetes Federation (IDF), the total number of people living with diabetes globally is projected to rise to643 million by 2030 and 783 million by 2045.

People with insulin-dependent diabetes need a continuous supply of insulin. There are two types of insulin therapy practiced today - multiple daily injections (MDI) therapy using syringes or insulin pens and pump therapy using insulin pumps. As per estimates approximately 40% of the Type 1 diabetes patients in the United States and even less of the international Type 1 diabetes patients use insulin pump therapy. An even smaller share of the U.S. and international insulin-intensive type 2 diabetes patients use insulin pump therapy, which presents significant opportunities for the stakeholders globally.

- Insulin administration through injections is expected to remain the standard of care across developed markets and emerging markets. However, in developed markets, the penetration of insulin pumps over the next decade is expected to reach ~55-60% for T1 diabetes ensive diabetes patients

• Senior Marketing Director, Tier I Insulin Pump Manufacturer, U.S.

Technological Advancements Drive the Global Insulin Pumps Market

Citing the lucrative prospects of the market, several players have launched technologically advanced products in the market, which are expected to further drive the market. For instance,

• In July 2023, Tandem Diabetes Care received U.S. Food and Drug Administration (FDA) clearance for the Tandem Mobi insulin pump for people with diabetes age 6 and up. The Tandem Mobi is fully controllable from a mobile app and is the world-s smallest durable automated insulin delivery system
• In April 2023, Medtronic received FDA approval for MiniMed- 780G System - World's first insulin pump with meal detection technology that provides automatic adjustments and corrections to sugar levels every 5 minuts

  
  

  Fill out the "Quick Inquiry Form" to request a sample copy.

  Insulin Pumps Market - Competitive Landscape-

  Some of the key players operating in the market include Modular Medical, Tandem Diabetes Care, Medtronic, Insulet, Roche, Ypsomed, AgVa Healthcare, Wuxi Apex Medical, SOOIL Development, among others.

  Insulin Pumps Market - Constraints/Challenges

  Relatively lower cost of injections vs insulin pumps, patients feeling of -wearing the disease- with insulin pumps, simplicity/ease of use of injections vs insulin pumps technology, and sufficient control achieved through the use of injections are some of the key factors that favor the preference of administering insulin through injections vs insulin pumps.

  Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Market-

  The players operating in this market are adopting organic and inorganic growth strategies such aes, launching new products, making strategic investments, and pursuing mergers and acquisitions to enhance their market position and broaden their customer base. For instance,

  • In Aug 2023, Modular Medical, a development-stage insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology announced a collaboration under which Phillips-Medisize (a MedTech CDMO) will be providing Modular Medical with design, development, and high-volume manufacturing capabilities
  • In February 2023, Insulet Corporation, a global leader intubeless insulin pump technology acquired assets related to Bigfoot-s pump-based automated insulin delivery (AID) technologies. In the same month, Insulet Corporation acquired the assets of Automated Glucose Control LLC (AGC), a company focused on developing and commercializing automated insulin delivery technology

  The Insulin Pumps Market is anticipated to gather increased momentum in the upcoming years owing to the advantages offered by insulin pumps coupled with the use of continuous glucose monitoring technology and automated insulin device (-AID-) algorithms, and increased awareness of insulin pump therapy.

  Insulin Pumps Market Report Scope

  
  

  Report Scope	Details
  Base Year Considered	2024
  Historical Data	2019 - 2023
  Forecast Period	2024 - 2029
  Growth Rate	CAGR 12%
  Segment Scope	Product, Indication and Country
  Regional Scope	North America (U.S. & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Rest of the World (Latin America, Middle East & Africa)
  Key Companies Mapped	Modular Medical, Tandem Diabetes Care, Medtronic, Insulet, Roche, Ypsomed  among others
  Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis